The 15 analysts offering 12-month price forecasts for BioNTech SE have a median target of 149.48, with a high estimate of 251.74 and a low estimate of 99.94. The median estimate represents a +42.78% increase from the last price of 104.69.
The current consensus among 17 polled investment analysts is to Buy stock in BioNTech SE. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.09
Reporting Date Nov 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.